Small Business Innovation Research · Small Business Technology Transfer
Cerus Corporation: SBIR & STTR awards
14 awards worth $3.54M to 1 companies since 2003 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).
Cerus Corporation's federal contracts and grants · All SBIR & STTR awards
Awards by year
| Year | Phase I | Phase II | Amount |
|---|---|---|---|
| 2006 | 2 | 0 | $200.0K |
| 2005 | 1 | 1 | $1.69M |
| 2004 | 3 | 1 | $1.05M |
| 2003 | 6 | 0 | $600.0K |
The latest year fills in over months: agencies report awards to SBIR.gov with a lag.
Latest matching awards
| Award | Company | Agency | Phase | Amount | Date |
|---|---|---|---|---|---|
| Vaccine-enhanced DLI to prevent cancer recurrence after stem cell transplantation | Cerus Corporation · California | Department of Health and Human Services · National Institutes of Health | STTR Phase I | $100.0K | 2006 |
| Vaccine-enhanced DLI to prevent cancer recurrence after stem cell transplantation | Cerus Corporation · California | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $100.0K | 2006 |
| Listeria Immunotherapy for Pancreatic and Ovarian Cancer | Cerus Corporation · California | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.13M | 2005 |
| Listeria-Based Ovarian Cancer Polyepitope Vaccines | Cerus Corporation · California | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $559.6K | 2005 |
| Validation of Amotosalen-HCI for Clinical Use | Cerus Corporation · California | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $748.6K | 2004 |
| Listeria-CEA Vaccine-Infected DC for Cancer Therapy | Cerus Corporation · California | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $100.0K | 2004 |
| MINIATURIZED INSTRUMENTATION FOR THE HTS OF DNA REPAIR | Cerus Corporation · California | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $100.0K | 2004 |
| Amotosalen PCT of Leukapheresis Units for GvHD Therapy | Cerus Corporation · California | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $100.0K | 2004 |
| Stem Cell Transplantation for Hemoglobinopathies in Dogs | Cerus Corporation · California | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $100.0K | 2003 |
| Use of Listeria as Colon Cancer Vaccine Adjuvants | Cerus Corporation · California | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $100.0K | 2003 |
| DNA Repair Inhibition and Cancer Therapy | Cerus Corporation · California | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $100.0K | 2003 |
| Validation of Amotosalen-HCI for Clinical Use | Cerus Corporation · California | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $100.0K | 2003 |
| Cord Blood Stem Cell Transplantation, Hemoglobinopathies | Cerus Corporation · California | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $100.0K | 2003 |
| Listeria-Based Vaccines for Ovarian Cancer Therapy | Cerus Corporation · California | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $100.0K | 2003 |
Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.